J&J vaginal mesh class-action suit grows in Australia

Johnson & Johnson ($JNJ) faces a class-action suit in Australia over allegedly faulty vaginal mesh that could become the country's largest. The West Australian reports that the lawsuit, launched by Shine Lawyers in October, already has 300 Australian women signed on. But thousands of women in the country had mesh implant surgery, and expectations are that the size of the class action could grow much higher. J&J is among several companies facing thousands of lawsuits in the U.S. and around the world alleging they marketed unsafe vaginal mesh implants. Story

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.